Evidence map›Paper›PMID 34869779›Full record

ArticleJournal of diabetes research2021

Low Molecular Weight Fucoidan Can Inhibit the Fibrosis of Diabetic Kidneys by Regulating the Kidney Lipid Metabolism.

Yan Wang, Yanlei Sun, Fengli Shao, Bo Zhang, Zhen Wang, Xinpeng Li

Open access · goldAbstract read
In one paragraph

Article in Journal of diabetes research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yan WangCollege of Pharmacy, Linyi University, Linyi, Shandong, China.
Yanlei SunLinyi Tumor Hospital, Linyi, Shandong, China.
Fengli ShaoCollege of Life Sciences, Linyi University, Linyi, Shandong, China.
Bo ZhangCollege of Pharmacy, Linyi University, Linyi, Shandong, China.
Zhen WangCollege of Pharmacy, Linyi University, Linyi, Shandong, China.
Xinpeng LiCollege of Pharmacy, Linyi University, Linyi, Shandong, China.ORCID https://orcid.org/0000-0003-1165-4723
Linyi University · CNLinyi People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, a diabetic kidney disease model was established by placing the test rats on a high-sugar/high-fat diet combined with streptozotocin induction. Histopathological examination (H&E, Masson, and PASM stain) showed pathological changes in the diabetic rat kidneys, in addition to fibrotic symptoms and collagen deposition. Immunohistochemistry and western blot analyses indicated that the diabetic condition significantly increased the expressions of fibrotic markers including collagen,

Indexed as

AnimalsAnticoagulantsBiomarkersChinaDiabetic NephropathiesDisease Models, AnimalFibrosisLipid MetabolismPolymerase Chain ReactionPolysaccharidesRatsAnticoagulantsBiomarkersfucoidanPolysaccharides

Identifiers

PMID34869779
PMCPMC8635909
OpenAlexW3215008131

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.